BillionToOne (BLLN) Other Non-Current Liabilities (2024 - 2025)
BillionToOne (BLLN) posted Other Non-Current Liabilities of $4.3 million for Q3 2025, up 57.37% sequentially from $2.8 million in Q4 2024.
BillionToOne (BLLN) Other Non-Current Liabilities (2024 - 2025) Analysis & Trends
BillionToOne has reported Other Non-Current Liabilities for 2 years, with the latest figure at $4.3 million in Q3 2025.
- Quarterly Other Non-Current Liabilities changed N/A year-over-year to $4.3 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $4.3 million (changed N/A YoY) and the FY2024 annual result came in at $2.8 million, changed N/A from the prior year.
- Other Non-Current Liabilities improved to $4.3 million in Q3 2025 per BLLN's latest filing, from $2.8 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $4.3 million in Q3 2025 and troughed at $2.8 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | BillionToOne | 6.88 Bn | 6.34 Bn | 79.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4.35 Mn |
| Dec 31, 2024 | 2.76 Mn |